GentiBio

GentiBio develops engineered regulatory T cells (EngTregs) to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Seed
Initial Investment Year
2020
Gentibio Hover Image